We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cow-derived COVID-19 Candidate Treatment Produces Four Times More Neutralizing Antibody, Suggests Data

News   Jun 11, 2020 | by Ruairi J Mackenzie, Science Writer for Technology Networks

 
Cow-derived COVID-19 Candidate Treatment Produces Four Times More Neutralizing Antibody, Suggests Data

Credit: Photo by Fusion Medical Animation on Unsplash https://unsplash.com/@fusion_medical_animation

 
 
Advertisement
 

RELATED ARTICLES

Phase 1 Clinical Trial of University of Queensland COVID-19 Vaccine Begins

News

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

READ MORE

Creating an Artificial Energy Source To Power Muscles

News

A new study in the Biophysical Journal outlines the work of scientists who have created a series of compounds that could serve as an alternative synthetic energy source for myosin.

READ MORE

The Colorful History of Plastid Evolution

News

In a new review, researchers have highlighted emerging genome data to provide new insight into plastid evolution.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE